Full Text View
Tabular View
No Study Results Posted
Related Studies
Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
This study is ongoing, but not recruiting participants.
Study NCT00004230   Information provided by National Cancer Institute (NCI)
First Received: January 28, 2000   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Additional conditions recognized in this trial
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
captopril
cyclophosphamide
radiation therapy
More general drug interventions related to this trial
Alkylating Agents
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Cardiovascular Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Robert H. Lurie Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services